Friday, April 30, 2021 10:10:01 PM
ALLO-501A, is intended for a potentially pivotal PhII trial, which should start in 2H, Previously it has been granted FDA fast track for R/R DLBCL. The company will host a webcast to review the data sets on May 19, at 2:30 pm PT/5:30 pm ET.
Recent ALLO News
- Allogene Therapeutics Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:06:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:04:23 PM
- Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 08/07/2024 08:02:54 PM
- Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL) • GlobeNewswire Inc. • 07/01/2024 12:30:00 PM
- Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 08:33:50 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:10:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:35:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:34:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:25:40 PM
- Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:40:57 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2024 08:38:13 PM
- Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock • GlobeNewswire Inc. • 05/13/2024 08:47:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:03:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:02:19 PM
- Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update • GlobeNewswire Inc. • 05/13/2024 08:01:00 PM
- Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update • GlobeNewswire Inc. • 05/06/2024 12:30:00 PM
- Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma • GlobeNewswire Inc. • 04/26/2024 12:30:00 PM
- Allogene Therapeutics Announces Q2 Investor Conference Participation • GlobeNewswire Inc. • 04/09/2024 12:30:00 PM
- Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update • GlobeNewswire Inc. • 03/14/2024 08:05:00 PM
- Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM